Loading
Latest filing published 04 Sept 2026 for Addex Therapeutics Ltd..
No signal scores available.
Timothy Mark Dyer discloses dealings in Addex Therapeutics Ltd. to SEC (Form 4). In total, 2 filings cover trades dated 2 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 4 September 2026, reports a transaction in Addex Therapeutics Ltd. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations